Nu Skin Enterprises (NYSE:NUS) had its price objective trimmed by Canaccord Genuity from $86.00 to $78.00 in a report released on Tuesday, Stock Ratings Network.com reports.
Shares of Nu Skin Enterprises (NYSE:NUS) traded down 1.20% on Tuesday, hitting $77.70. The stock had a trading volume of 730,200 shares. Nu Skin Enterprises has a one year low of $40.32 and a one year high of $140.50. The stock’s 50-day moving average is $82.10 and its 200-day moving average is $103.. The company has a market cap of $4.622 billion and a P/E ratio of 16.09. Nu Skin Enterprises also saw some unusual options trading activity on Monday. Investors purchased 6,848 put options on the company. This is an increase of approximately 324% compared to the typical volume of 1,617 put options.
Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Monday, March 3rd. The company reported $2.02 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.99 by $0.03. The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.07 billion. During the same quarter last year, the company posted $0.97 earnings per share. Nu Skin Enterprises’s revenue was up 82.3% compared to the same quarter last year. On average, analysts predict that Nu Skin Enterprises will post $6.24 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, March 26th. Shareholders of record on Friday, March 14th will be paid a dividend of $0.345 per share. This represents a $1.38 annualized dividend and a dividend yield of 1.75%. The ex-dividend date is Wednesday, March 12th. This is a positive change from Nu Skin Enterprises’s previous quarterly dividend of $0.30.
NUS has been the subject of a number of other recent research reports. Analysts at Bank of America raised their price target on shares of Nu Skin Enterprises from $2.00 to $85.00 in a research note on Tuesday. Separately, analysts at Wedbush cut their price target on shares of Nu Skin Enterprises to $105.00 in a research note on Monday. Finally, analysts at Ned Davis Research upgraded shares of Nu Skin Enterprises from a neutral rating to a buy rating in a research note on Monday, February 24th. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Nu Skin Enterprises has an average rating of Buy and an average price target of $102.10.
Nu Skin Enterprises, Inc is a global direct selling company with operations in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively.
To view Canaccord Genuity’s full report, visit Canaccord Genuity’s official website.
Receive News & Ratings for Nu Skin Enterprises Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.